Clinical Trials Directory

Trials / Completed

CompletedNCT06036251

COVID-19 Pandemic Induced Stress and Symptoms

COVID-19 Pandemic Induced Stress and Symptoms - Follow-up Study

Status
Completed
Phase
Study type
Observational
Enrollment
415 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The previous survey of oncology patients at University of California, San Francisco in 2020-2021 found an alarmingly high symptom burden and high levels of stress and loneliness among respondents. This is a follow-up study with the same sample of oncology patients and survivors who participated in the previous study

Detailed description

OBJECTIVES: 1. Evaluate for associations among general and disease-specific measures of stress and measures of social isolation and loneliness. 2. Evaluate for associations between general and disease-specific stress and common symptoms associated with cancer and its treatments. 3. Evaluate for associations between social isolation and loneliness and common symptoms associated with cancer and its treatments. 4. Evaluate for associations between social isolation and loneliness and health behaviors and quality of life (QOL) as compared to our last survey. as a baseline. 5. Evaluate for changes in stress, social isolation, loneliness and symptom burden between the two time points. OUTLINE: Patients will be asked to complete self-report questionnaires online. Questionnaires will take approximately 60 minutes to complete. and directed to take rest periods at 20 minute intervals. Participants will be given two weeks to complete the instruments.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnairesSelf-reported quality of life (QOL) measures completed online

Timeline

Start date
2023-02-01
Primary completion
2023-04-30
Completion
2023-04-30
First posted
2023-09-13
Last updated
2023-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06036251. Inclusion in this directory is not an endorsement.